Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures
Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures PLAINSBORO, N.J., April 23, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the U.S.
View HTML
Toggle Summary Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter
Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter PLAINSBORO, N.J., April 9, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that
View HTML
Toggle Summary Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged
Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged PLAINSBORO, N.J., April 5, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported preliminary revenues for the first quarter ended March 31, 2002.
View HTML
Toggle Summary Integra LifeSciences Announces Investor Forum at the American Association of Neurological Surgeons Meeting on April 9, 2002
Integra LifeSciences Announces Investor Forum at the American Association of Neurological Surgeons Meeting on April 9, 2002 PLAINSBORO, N.J., March 8, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced today that it has scheduled an Investor Forum at the American
View HTML
Toggle Summary Integra LifeSciences Reports Record Fourth Quarter and Full Year 2001 Earnings on a 'Fully Taxed' Basis
Integra LifeSciences Reports Record Fourth Quarter and Full Year 2001 Earnings on a 'Fully Taxed' Basis Operating Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $6.1 Million for the Fourth Quarter of 2001 and $20.2 Million for the Full Year 2001 PLAINSBORO, N.J., Feb.
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J. Feb. 20, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced
View HTML
Toggle Summary Integra LifeSciences Reports Preliminary Fourth Quarter 2001 Revenues -- Product Sales Increase 26%; Full Financial Results to be Reported on February 27, 2002
Integra LifeSciences Reports Preliminary Fourth Quarter 2001 Revenues -- Product Sales Increase 26@Full Financial Results to be Reported on February 27, 2002 PLAINSBORO, N.J., Jan. 29, 2002 (PRIMEZONE) -- Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:
View HTML
Toggle Summary Integra LifeSciences to Present at the US Bancorp Piper Jaffray Health Care Conference
Integra LifeSciences to Present at the US Bancorp Piper Jaffray Health Care Conference PLAINSBORO, N.J., Jan 22, 2002 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the US Bancorp Piper Jaffray Health Care Conference at
View HTML
Toggle Summary Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent
Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent PLAINSBORO, N.J., Jan 14, 2002 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing Helitene® Absorbable
View HTML
Toggle Summary FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge
FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge PLAINSBORO, N.J.--(BUSINESS WIRE)--Jan. 11, 2002--Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Orthopedic and Rehabilitation Devices Panel of the United States Food and
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of NeuroSupplies, Inc., a Specialty Distributor of Neurology Supplies
Integra LifeSciences Announces Acquisition of NeuroSupplies, Inc., a Specialty Distributor of Neurology Supplies PLAINSBORO, N.J., Dec 7, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced today that it has acquired NeuroSupplies, Inc., a specialty
View HTML
Toggle Summary Integra LifeSciences Reports Record Third Quarter Net Income on 31% Growth in Product Sales
Integra LifeSciences Reports Record Third Quarter Net Income on 31 PLAINSBORO, N.J., Nov 7, 2001 (BUSINESS WIRE) -- Operating Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $5.4 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance PLAINSBORO, N.J., Oct 31, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has
View HTML
Toggle Summary Integra LifeSciences to Present at the Techvest 3rd Annual Conference on Tissue Repair, Replacement and Regeneration
Integra LifeSciences to Present at the Techvest 3rd Annual Conference on Tissue Repair, Replacement and Regeneration PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 18, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Techvest 3rd Annual
View HTML
Toggle Summary Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents
Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 17, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that the United States District Court for the Southern
View HTML